Accurate Placement of Artificial Emboli

Rosenbluth, Paul R.

doi:10.1001/jama.1960.63030030016022c

Cited by 16 publications

(3 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our young patient tolerated the procedure without increasing signs of cardiac failure or fluid overloading following the injections of a total of 270 (200) ml of NaCl and 80 (60) ml Conray during one embolisation session. Tzonos et al (1975), Luessenhop (1975) and Rosenbluth et al (1960) have found in their patients with inter-2 Schwedische Kugellagerfabriken, Ernst-Sachs-StraBe 2-8, D-8720 Schweinfurt nal carotid artery embolisation that the emboli may go astray en route through the angioma landing in other areas, in homolateral or contralateral vessels. Aside from the blood flow through the angioma, another factor which determines the path of the spheres is the state of the overall circulation at the moment of the injection.…”

Section: Discussionmentioning

confidence: 99%

Artificial Embolisation of Inoperable Dura and Sinus Angioma in an Infant¹

Kohler¹,

Tzonos²,

Gustorf³

1977

Neuropediatrics

View full text Add to dashboard Cite

A seven month old boy suffered fron an inoperable extensive bilateral vascular malformation of the dura and the sinus system. This congenital lesion was artificially embolised in two sessions by injecting several hundred small steel spheres through the external carotid arteries. Clinical and neuroradiological reexaminations revealed a favourable result in this case. The technique and risks of this method which so far had not been applied in infants are demonstrated.

show abstract

Section: Discussionmentioning

confidence: 99%

Artificial Embolisation of Inoperable Dura and Sinus Angioma in an Infant¹

Kohler¹,

Tzonos²,

Gustorf³

1977

Neuropediatrics

View full text Add to dashboard Cite

show abstract

“…When X-ray fluoroscopy is used, the embolic agents are usually mixed with a contrast agent, and the mixture is injected via the catheter. The X-ray fluoroscopy monitors the injection and the flow of the mixture in real time, and the catheter guides the delivery of the embolic agents to the vessels of interest 52 . X-ray fluoroscopy has many applications that are extraordinarily diverse.…”

Section: Radiopaque Nanoparticles and Biomaterials For Atherosclerosimentioning

confidence: 99%

Radiopaque nano and polymeric materials for atherosclerosis imaging, embolization and other catheterization procedures

Tian

Feng

et al. 2018

Acta Pharmaceutica Sinica B

View full text Add to dashboard Cite

A review of radiopaque nano and polymeric materials for atherosclerosis imaging and catheterization procedures is presented in this paper. Cardiovascular diseases (CVDs) are the leading cause of death in the US with atherosclerosis as a significant contributor for mortality and morbidity. In this review paper, we discussed the physics of radiopacity and X-ray/CT, clinically used contrast agents, and the recent progress in the development of radiopaque imaging agents and devices for the diagnosis and treatment of CVDs. We focused on radiopaque imaging agents for atherosclerosis, radiopaque embolic agents and drug eluting beads, and other radiopaque medical devices related to catheterization procedures to treat CVDs. Common strategies of introducing radiopacity in the polymers, together with examples of their applications in imaging and medical devices, are also presented.

show abstract

“…It was developed in 1953 by Dr Sven-Ivar Seldinger (1921–1998), a Swedish radiologist from Mora Municipality, Dalarna County. Embolization is another procedure, nonsurgical, and minimally invasive, through placement of artificial embolus, used to treat a wide variety of conditions affecting different organs of the human body [2]. For tumor therapy, this treatment is used to slow or stop blood supply for reducing the size of the tumor [3, 4].…”

Section: Introductionmentioning

confidence: 99%

Transcatheter Arterial Chemoembolization: History for More than 30 Years

Guan

Wang

2012

ISRN Gastroenterology

View full text Add to dashboard Cite

Transcatheter arterial chemoembolization (TACE) is a minimally invasive technique to treat liver tumors, particularly hepatocellular carcinoma (HCC). TACE was used in early times to treat liver tumor patients with emergencies caused by symptomatic humoral hypercalcemia and develops gradually from the procedures of diagnostic angiography and transcatheter injection of agents and is in particular performed in the treatment of HCC. Since the beginning of this century, TACE has been used extensively in the palliative treatment of unresectable HCC. In recent years, it is indicated in selected patients with early-stage HCC. This review introduces the evolution of TACE for more than 30 years, its role in comprehensive treatment of HCC, the tendency of its refinement in future, and the combination use of TACE with other local ablative methods for the curative result of HCC.

show abstract

Accurate Placement of Artificial Emboli

Cited by 16 publications

References 1 publication

Artificial Embolisation of Inoperable Dura and Sinus Angioma in an Infant¹

Artificial Embolisation of Inoperable Dura and Sinus Angioma in an Infant¹

Radiopaque nano and polymeric materials for atherosclerosis imaging, embolization and other catheterization procedures

Transcatheter Arterial Chemoembolization: History for More than 30 Years

Contact Info

Product

Resources

About

Accurate Placement of Artificial Emboli

Cited by 16 publications

References 1 publication

Artificial Embolisation of Inoperable Dura and Sinus Angioma in an Infant1

Artificial Embolisation of Inoperable Dura and Sinus Angioma in an Infant1

Radiopaque nano and polymeric materials for atherosclerosis imaging, embolization and other catheterization procedures

Transcatheter Arterial Chemoembolization: History for More than 30 Years

Contact Info

Product

Resources

About

Artificial Embolisation of Inoperable Dura and Sinus Angioma in an Infant¹

Artificial Embolisation of Inoperable Dura and Sinus Angioma in an Infant¹